1. P571 Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC). (16th January 2018) Authors: Pulusu, S S R; Srinivasan, A; Krishnaprasad, K; Cheng, D; Mogilevski, T; Flanagan, E; Keung, C; Wu, C; Prosser, R; Sawyer, E; Rizvi, Q -U -A; Su, H; Leung, W -K; Edmundson, A; Cooke, S; Mahy, G; Thin, L; Radford-Smith, G; Sparrow, M; Andrews, J M Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗